Identification and characterization of Xenopus CD8+ T cells expressing an NK cell-associated molecule

被引:0
|
作者
Rau, L
Gantress, J
Bell, A
Stewart, R
Horton, T
Cohen, N
Horton, J
Robert, J
机构
[1] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA
[2] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3HP, England
关键词
CD8(+); NK/T cell; NK cell-associated molecule; Xenopus;
D O I
10.1002/1521-4141(200206)32:6<1574::AID-IMMU1574>3.0.CO;2-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Growing evidence suggests that some immune responses are mediated not only by conventional and distinct NK cells and CTL, but also by T cell subsets expressing NK receptors and NK cell-associated molecules. Consistent with our previously published finding that the mAb 1F8 identifies non-T/non-B cells in Xenopus that effect NK-like killing in vitro, we now report that in vivo treatment with this mAb impairs rejection of transplanted MHC class I-negative tumor cells. However, we also find that the NK cell-associated molecule recognized by mAb 1F8 is expressed by a minor population of CD8(+) T cells, in which fully rearranged TCRP mRNA of at least three different V families can be identified, by contrast, 1F8(+)/CD8(NK) cells lack such TCRP message. Additionally, the expression of the NK cell-associated molecule can be induced in vitro by a transient submitogenic stimulation of naive CD8(+) T cells with PMA and ionomycin. Such induced expression of 1F8 also occurs in alloantigen-activated CTL and is coincident with a down-regulation of MHC-specific cytotoxicity. Taken together, these new data suggest that regulation of CD8(+) T cell activity involving NK cell-associated molecules is a general and evolutionarily ancient phenomenon.
引用
收藏
页码:1574 / 1583
页数:10
相关论文
共 50 条
  • [21] A CD8+ T cell-associated immune gene panel for prediction of the prognosis and immunotherapeutic effect of melanoma
    Sun, Shanwen
    Zhi, Zhengke
    Su, Yang
    Sun, Jingxian
    Li, Qianjun
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [22] CD8+ T cells and NK cells: parallel and complementary soldiers of immunotherapy
    Rosenberg, Jillian
    Huang, Jun
    CURRENT OPINION IN CHEMICAL ENGINEERING, 2018, 19 : 9 - 20
  • [23] Viral persistence and fatal CD8 T cell-associated pathology are consequences of NK cell-mediated killing of activated CD4 T cells
    Waggoner, Stephen
    Selin, Liisa
    Welsh, Raymond
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [24] Direct Presentation Regulates the Magnitude of the CD8+ T Cell Response to Cell-Associated Antigen through Prolonged T Cell Proliferation
    Tatum, Angela M.
    Watson, Alan M.
    Schell, Todd D.
    JOURNAL OF IMMUNOLOGY, 2010, 185 (05): : 2763 - 2772
  • [25] Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells
    Ohkawa, T
    Seki, S
    Dobashi, H
    Koike, Y
    Habu, Y
    Ami, K
    Hiraide, H
    Sekine, I
    IMMUNOLOGY, 2001, 103 (03) : 281 - 290
  • [26] NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen
    Vankayalapati, R
    Klucar, P
    Wizel, B
    Weis, SE
    Samten, B
    Safi, H
    Shams, H
    Barnes, PF
    JOURNAL OF IMMUNOLOGY, 2004, 172 (01): : 130 - 137
  • [27] A critical role for NK cells in exosome-induced CD8+ T cell cytotoxicity
    Saunderson, S. C.
    McLellan, A. D.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 1145 - 1145
  • [28] Porcine NK Cells Stimulate Proliferation of Pseudorabies Virus-Experienced CD8+ and CD4+ CD8+ T Cells
    De Pelsmaeker, Steffi
    Devriendt, Bert
    De Regge, Nick
    Favoreel, Herman W.
    FRONTIERS IN IMMUNOLOGY, 2019, 9
  • [29] A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory
    Bourgeois, C
    Rocha, B
    Tanchot, C
    SCIENCE, 2002, 297 (5589) : 2060 - 2063
  • [30] Selective bystander proliferation of memory CD4+ and CD8+ T cells upon NK T or T cell activation
    Eberl, G
    Brawand, P
    MacDonald, HR
    JOURNAL OF IMMUNOLOGY, 2000, 165 (08): : 4305 - 4311